ORBIMED ADVISORS LLC Mirum Pharmaceuticals, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$10.96M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

+7.97%
quarter

Mirum Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +86.72% 242.39K shares 5.52M $21.01 521.89K
Q2 2022 share Increase +935.19% 252.5K shares 4.84M $19.46 279.5K
Q1 2022 share Increase 0.00% 27K shares 595K $22.02 27K
Q1 2020 share Decrease -100.00% -71.3K shares -1.74M $14 0
Q4 2019 share Increase 0.00% 71.3K shares 1.74M $24.52 71.3K